Skip to main content
Clinical Trials/NCT05488782
NCT05488782
Completed
Not Applicable

A Pilot RCT of a Remotely Delivered Self-management Program (TEAM-Red) for Depressed Young African American Women at Risk for Hypertension (HTN)

Jennifer B. Levin2 sites in 1 country83 target enrollmentJanuary 30, 2023
ConditionsDepression
InterventionsTEAM-RedWaitlist

Overview

Phase
Not Applicable
Intervention
TEAM-Red
Conditions
Depression
Sponsor
Jennifer B. Levin
Enrollment
83
Locations
2
Primary Endpoint
Phase 1 TEAM vs WL change in 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-up
Status
Completed
Last Updated
4 days ago

Overview

Brief Summary

The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.

Registry
clinicaltrials.gov
Start Date
January 30, 2023
End Date
September 18, 2025
Last Updated
4 days ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Sponsor
Jennifer B. Levin
Responsible Party
Sponsor Investigator
Principal Investigator

Jennifer B. Levin

Principal Investiagator

University Hospitals Cleveland Medical Center

Eligibility Criteria

Inclusion Criteria

  • Phase 1 Inclusion Criteria:
  • Registered on Research Goes Red;
  • Self-identified African American female ages 18-49;
  • current depression as measured by a score of ≥10 on the 9-item Patient Health Questionnaire (PHQ-9),
  • Have at least one of the following self or chart-recorded HTN risk factors: body mass index (BMI) greater ≥ 30, HbA1c \>5.75, at least one outpatient reading of systolic blood pressure (BP) ≥ 130 mm Hg or diastolic ≥90 mmHg, current smoker, or LDL ≥100 mg/dl in the last 12 months;
  • Are able to participate in study procedures.

Exclusion Criteria

  • Unwilling/unable to provide informed consent;
  • Imminent suicide risk,
  • A current diagnosis of hypertension or use of antihypertensive medications.
  • Phase 2 Inclusion Criteria
  • Self-identified AA female ages 18-49;
  • Endorses either: a past or current history of depression, current depression as measured by a score of at least a 5 on the 9-item Patient Health Questionnaire (PHQ-9), or indicate feelings of stress or discrimination that impact their functioning
  • Have at least one of the following self or chart-recorded HTN risk factors: BMI greater ≥ 30,26 HbA1c \>5.75,27 at least one outpatient reading of systolic BP ≥ 130 mm Hg or diastolic ≥90 mmHg, current smoker, or LDL ≥100 mg/dl in the last 12 months;
  • Are able to participate in study procedures.
  • Phase 2 Exclusion Criteria
  • Unwilling/unable to provide informed consent;

Arms & Interventions

TEAM-Red

Five 60-minute group sessions with 6-10 patients. These sessions will be held weekly and delivered remotely via videoconference

Intervention: TEAM-Red

Enhanced Waitlist (eWL)

After the week 12 follow up visit, subjects in the Waitlist group will receive the TEAM Red intervention

Intervention: Waitlist

Outcomes

Primary Outcomes

Phase 1 TEAM vs WL change in 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-up

Time Frame: Baseline to 12 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 1 change in 9-item Patient Health Questionnaire (PHQ-9) total score at 24-week follow up

Time Frame: Baseline to 24 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 2 TEAM-Red vs eWL 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-up

Time Frame: Baseline to 12 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 2 change in 9-item Patient Health Questionnaire (PHQ-9) total score at 24-week follow-up

Time Frame: Baseline to 24 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 2 TEAM-Red vs eWL 10-item Perceived Stress Scale (PSS-10) total score at 12-week follow-up

Time Frame: Baseline to 12 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Phase 2 change in 10-item Perceived Stress Scale (PSS-10) total score at 24-week follow up

Time Frame: Baseline to 24 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Secondary Outcomes

  • Phase 1 TEAM-Red vs eWL 10-item Perceived Stress Scale (PSS-10) total score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 1 change in 10-item Perceived Stress Scale (PSS-10) total score at 24-week follow up(Baseline to 24 weeks)
  • Phase 1 TEAM-Red vs eWL 12-item Short Form Survey (SF-12) mental component score at 12-week follow up(Baseline to 12 weeks)
  • Phase 1 TEAM-Red vs eWL 12-item Short Form Survey (SF-12) physical component score at 12-week follow up(Baseline to 12 weeks)
  • Phase 1 change in 12-item Short Form Survey (SF-12) mental component score at 24-week follow up(Baseline to 24 weeks)
  • Phase 1 change in 12-item Short Form Survey (SF-12) physical component score at 24-week follow up(Baseline to 24 weeks)
  • Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) mental component score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) physical component score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 2 change in 12-item Short Form Survey (SF-12) mental component score at 24-week follow up(Baseline to 24 weeks)
  • Phase 2 change in 12-item Short Form Survey (SF-12) physical component score at 24-week follow up(Baseline to 24 weeks)
  • Phase 1 and Phase 2 TEAM-Red vs eWL change in 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 1 and Phase 2 change in 9-item Patient Health Questionnaire (PHQ-9) total score at 24-week follow up(Baseline to 24 weeks)
  • Phase 1 and Phase 2 TEAM-Red vs eWL change in 10-item Perceived Stress Scale (PSS-10) total score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 1 and Phase 2 change in 10-item Perceived Stress Scale (PSS-10) total score at 24-week follow up(Baseline to 24 weeks)
  • Phase 1 and Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) mental component score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 1 and Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) physical component score at 12-week follow-up(Baseline to 12 weeks)
  • Phase 1 and Phase 2 change in 12-item Short Form Survey (SF-12) mental component score at 24-week follow up(Baseline to 24 weeks)
  • Phase 1 and Phase 2 change in 12-item Short Form Survey (SF-12) physical component score at 24-week follow up(Baseline to 24 weeks)

Study Sites (2)

Loading locations...

Similar Trials